Evidence map›Paper›PMID 34266400›Full record

Observational studyBMC psychiatry2021

Fear and depression during the COVID-19 outbreak in Cameroon: a nation-wide observational study.

Joseph Nelson Siewe Fodjo, Leonard Ngarka, Wepnyu Y Njamnshi, Leonard N Nfor, Michel K Mengnjo, Edwige Laure Mendo, Samuel A Angwafor, Jonas Guy Atchou Basseguin, Cyrille Nkouonlack, Edith N Njit and 19 more

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in BMC psychiatry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Observational
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors at 4 institutions in 5 countries.

Joseph Nelson Siewe FodjoGlobal Health Institute, University of Antwerp, Antwerp, Belgium.
Leonard NgarkaBrain Research Africa Initiative (BRAIN), Yaoundé, Cameroon.
Wepnyu Y NjamnshiBrain Research Africa Initiative (BRAIN), Yaoundé, Cameroon.
Leonard N NforBrain Research Africa Initiative (BRAIN), Yaoundé, Cameroon.
Michel K MengnjoBrain Research Africa Initiative (BRAIN), Yaoundé, Cameroon.
Edwige Laure MendoBrain Research Africa Initiative (BRAIN), Yaoundé, Cameroon.
Samuel A AngwaforBrain Research Africa Initiative (BRAIN), Yaoundé, Cameroon.
Jonas Guy Atchou BasseguinBrain Research Africa Initiative (BRAIN), Yaoundé, Cameroon.
Cyrille NkouonlackBrain Research Africa Initiative (BRAIN), Yaoundé, Cameroon.
Edith N NjitBrain Research Africa Initiative (BRAIN), Yaoundé, Cameroon.
Nene AhidjoBrain Research Africa Initiative (BRAIN), Yaoundé, Cameroon.
Eric S ChokoteBrain Research Africa Initiative (BRAIN), Yaoundé, Cameroon.
Fidèle DemaBrain Research Africa Initiative (BRAIN), Yaoundé, Cameroon.
Julius Y FonsahBrain Research Africa Initiative (BRAIN), Yaoundé, Cameroon.
Godwin Y TatahBrain Research Africa Initiative (BRAIN), Yaoundé, Cameroon.
Nancy PalmerBrain Research Africa Initiative (BRAIN), Yaoundé, Cameroon.
Paul F Seke EtetBrain Research Africa Initiative (BRAIN), Yaoundé, Cameroon.
Dennis PalmerBrain Research Africa Initiative (BRAIN), Yaoundé, Cameroon.
Dickson S NsaghaBrain Research Africa Initiative (BRAIN), Yaoundé, Cameroon.
Daniel E Etya'aleBrain Research Africa Initiative (BRAIN), Geneva, Switzerland.
Stephen PerrigBrain Research Africa Initiative (BRAIN), Geneva, Switzerland.
Roman SztajzelBrain Research Africa Initiative (BRAIN), Geneva, Switzerland.
Jean-Marie AnnoniBrain Research Africa Initiative (BRAIN), Geneva, Switzerland.
Anne-Cécile Zoung-Kanyi BissekDivision of Health Operations Research, Ministry of Public Health, Yaoundé, Cameroon.
Rose G F LekeBrain Research Africa Initiative (BRAIN), Yaoundé, Cameroon.
Marie-Thérèse Abena Ondoa ObamaBrain Research Africa Initiative (BRAIN), Yaoundé, Cameroon.
John N NkengasongCDC Africa, African Union, Addis Ababa, Ethiopia.
Robert ColebundersGlobal Health Institute, University of Antwerp, Antwerp, Belgium.
Alfred K NjamnshiBrain Research Africa Initiative (BRAIN), Yaoundé, Cameroon. alfred.njamnshi@brainafrica.org.ORCID 0000-0003-0052-1511
University of Antwerp · BEAfrican Union · ETAllen Institute for Brain Science · USMinistry of Public Health · CM

Funding

European Research Council
6 · The paper itself

Abstract

backgroundThe COVID-19 pandemic has been associated with significant psychological and social distress worldwide. We investigated fear and depression among adults in Cameroon during different phases of the COVID-19 outbreak.

methodsAn online survey was conducted in Cameroon from June-December 2020 using a structured questionnaire. Socio-demographic data and information regarding COVID-19 history were obtained. Fear and depressive symptoms were assessed using the Fear of COVID-19 score (FCV-19S) and the Patient Health Questionnaire (PHQ-9), respectively. Responses were clustered in weeks to better appreciate their evolution over time.

resultsOverall, 7381 responses from all ten regions of Cameroon were analysed (median age: 30 years, 73.3% male). The prevalence of depression (PHQ-9 score ≥ 10) was 8.4%, and that of high fear of COVID-19 (FCV-19S scores ≥19) was 57.4%. These rates were similar across genders, age-groups, and region of residence. While mean weekly PHQ-9 scores remained fairly stable throughout the study period (range: 2.53-3.21; p = 0.101), mean FCV-19S scores were highest during the early weeks but decreased significantly thereafter (from 20.31 to 18.34; p <  0.001). Multivariate analyses revealed that having a postgraduate degree, a history of quarantine, flu-like symptoms during the past 14 days, and higher FCV-19S scores were associated with more severe depressive symptoms, while obtaining COVID-19 information from various sources reduced the odds for depression.

conclusionDepression amidst the COVID-19 crisis is less prevalent in Cameroon than in other countries. Prompt and widespread dissemination of adequate COVID-19 information may reduce the risks for depression by dispelling fear and anxiety among Cameroonians.

Indexed as

COVID-19PandemicsAdultCameroonDepressionFearFemaleHumansMaleSARS-CoV-2CameroonCOVID-19DepressionFCV-19SFearPHQ-9

Identifiers

PMID34266400
PMCPMC8280628
OpenAlexW3129114938

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.